Pharmicell Co., Ltd. (KRX:005690)

South Korea · Delayed Price · Currency is KRW

11,850

+260 (2.24%)

Last updated: Aug 12, 2026, 2:21 PM KST

Pharmicell Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Jun '14 Jun 30, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009
Revenue	23,945	33,405	11,112	10,282	7,217	7,188
Revenue Growth	-3.60%	200.63%	8.07%	42.47%	0.40%	-13.68%
Gross Profit	5,446	8,677	1,257	-1,661	993.69	2,105
Operating Income	-9,291	-7,848	-14,250	-15,379	-10,477	-2,487
Net Income	-26,782	-25,701	-17,643	-18,173	-11,859	-3,953
Earnings Per Share	-613.75	-607.88	-467.00	-695.00	-5723.00	-257.52
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2013
Period Ending	Jun '14 Jun 30, 2014	Dec '13 Dec 31, 2013
Bio Business Department	7,900	12,102
Chemical Business Department	16,045	21,303
Total	23,945	33,405

Cash & Debt

Fiscal Year	Current	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Jun '14 Jun 30, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009
Cash & Investments	9,443	2,512	21,089	9,088	8,754	7,944
Total Debt	11,744	8,841	27,168	15,217	13,894	8,710
Net Cash (Debt)	-2,301	-6,330	-6,078	-6,129	-5,140	-766.38
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-52.72	-149.71	-160.89	-234.39	-2480.35	-49.92

Cash Flow & CapEx

Fiscal Year	TTM	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Jun '14 Jun 30, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009
Operating Cash Flow	-7,547	-2,688	-11,868	-16,166	-8,415	-5,141
Capital Expenditures	-272.69	-478.99	-2,480	-664.72	-531.05	-721.27
Free Cash Flow	-7,820	-3,167	-14,348	-16,831	-8,946	-5,863
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Jun '14 Jun 30, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009
Gross Margin	22.74%	25.97%	11.32%	-16.15%	13.77%	29.29%
Operating Margin	-38.80%	-23.49%	-128.24%	-149.57%	-145.17%	-34.59%
Pretax Margin	-111.71%	-76.94%	-150.11%	-179.64%	-164.75%	-54.72%
Profit Margin	-111.85%	-76.94%	-158.78%	-176.73%	-164.31%	-54.99%
FCF Margin	-32.66%	-9.48%	-129.13%	-163.69%	-123.95%	-81.56%

Valuation

Fiscal Year	Current	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Aug '26 Aug 12, 2026	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009
PS Ratio	29.04	4.91	19.22	36.05	24.02	10.50